CTEV
Claritev Corporation NYSE Listed Apr 3, 2020$29.42
-1.11%
vs $29.75
Mkt Cap $483.5M
52w Low $13.47
27.0% of range
52w High $72.58
50d MA $24.16
200d MA $35.48
P/E (TTM)
—
EV/EBITDA
9.8x
P/B
—
Debt/Equity
-26.6x
ROE
163.5%
P/FCF
-39.4x
RSI (14)
62.50
ATR (14)
$2.66
Beta
0.54
50d MA
$24.16
200d MA
$35.48
Avg Volume
190.0K
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.
115 Fifth Avenue · New York City, NY 10003 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 26.47 | -3.2% | -8.5% | +11.5% | +9.8% | -3.8% | -3.3% | — |
| Feb 23, 2026 | AMC | 0.85 | -4.88 | -674.1% | 23.23 | -0.9% | -41.6% | +9.2% | -4.4% | -4.9% | +7.1% | — |
| Nov 7, 2025 | AMC | -3.12 | -4.07 | -30.4% | 69.25 | +4.9% | -16.5% | -1.0% | +2.4% | -24.6% | -2.1% | — |
| Aug 6, 2025 | AMC | -2.69 | 0.32 | +111.9% | 51.14 | -0.3% | +7.4% | +3.4% | +8.4% | +6.6% | +7.1% | — |
| May 8, 2025 | AMC | -2.20 | -3.43 | -55.9% | 21.58 | -0.4% | +0.4% | +0.6% | +14.8% | +7.3% | +1.8% | — |
| Feb 25, 2025 | AMC | -9.81 | -5.14 | +47.6% | 19.61 | -0.7% | +19.9% | -1.5% | -9.3% | -8.3% | +0.0% | — |
| Nov 5, 2024 | AMC | -2.37 | -1.85 | +21.9% | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29 | Canaccord Genuity | Initiates | Buy | $32 | $24.56 | $25.54 | +4.0% | +2.3% | +7.4% | +5.0% | -7.3% | +4.9% |
| Apr 24 | Barclays | Initiates | Overweight | $28 | $20.30 | $22.54 | +11.0% | +17.3% | +1.7% | -3.0% | -1.8% | +5.5% |
| Mar 19 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $16.28 | $15.70 | -3.6% | -5.8% | -2.9% | +3.8% | -0.6% | +1.2% |
| Feb 25 | Citigroup | Maintains | Buy → Buy | — | $13.57 | $13.54 | -0.2% | +9.2% | -4.4% | -4.9% | +7.1% | +17.2% |
| Feb 24 | Guggenheim | Maintains | Buy → Buy | — | $23.23 | $23.01 | -0.9% | -41.6% | +9.2% | -4.4% | -4.9% | +7.1% |
| Feb 24 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $23.23 | $23.01 | -0.9% | -41.6% | +9.2% | -4.4% | -4.9% | +7.1% |
| Jan 9 | Citigroup | Maintains | Buy → Buy | — | $31.21 | $30.01 | -3.8% | -7.3% | +10.4% | +1.4% | -6.0% | -1.3% |
| Nov 10 | Citigroup | Maintains | Buy → Buy | — | $69.25 | $72.67 | +4.9% | -16.5% | -1.0% | +2.4% | -24.6% | -2.1% |
| Oct 22 | Citigroup | Upgrade | Neutral → Buy | — | $66.00 | $66.03 | +0.0% | +0.1% | +0.5% | +4.9% | +2.4% | -0.3% |
| Oct 21 | Citigroup | Upgrade | Neutral → Buy | — | $58.52 | $63.08 | +7.8% | +12.8% | +0.1% | +0.5% | +4.9% | +2.4% |
| Aug 15 | Piper Sandler | Maintains | Overweight → Overweight | — | $67.81 | $69.94 | +3.1% | +5.6% | +0.8% | -6.2% | -2.4% | +3.9% |
| May 29 | Piper Sandler | Upgrade | Neutral → Overweight | — | $26.66 | $29.08 | +9.1% | +34.8% | +7.0% | -0.5% | -1.7% | -2.1% |
| Mar 10 | Piper Sandler | Maintains | Neutral → Neutral | — | $18.26 | $17.94 | -1.8% | -5.0% | +12.7% | +2.3% | +1.2% | -0.9% |
| Jan 10 | Citigroup | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| Sep 23 | Citigroup | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Carol NutterOff | SVP, Chief People Officer | Buy | 875 | $28.41 | $25K | 46,941 | +7.70% | -3.00% |
| May 19, 2026 | Prince John MichaelDir | — | Buy | 10,000 | $16.00 | $160K | 31,662 | +31.11% | +6.02% |
| May 18, 2026 | Dalton TravisDir/Off | Pres., CEO & Executive Chair | Buy | 11,200 | $11.88 | $133K | 45,872 | +31.11% | +6.02% |
| May 18, 2026 | Dalton TravisDir/Off | Pres., CEO & Executive Chair | Buy | 9,720 | $12.92 | $126K | 34,672 | +31.11% | +6.02% |
| May 18, 2026 | Kim MichaelOff | EVP, Chief Digital Officer | Buy | 3,000 | $16.65 | $50K | 185,878 | +31.11% | +6.02% |
8-K · 7.01
! Medium
Claritev Corporation -- 8-K 7.01: Regulation FD Disclosure
May 18
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
This vague boilerplate disclosure lacks material information, suggesting the company may be avoiding substantive announcements or facing uncertainty it prefers not to detail to investors.
Mar 16
8-K · 8.01
!! High
Claritev Corporation -- 8-K 8.01: Material Event / Announcement
Claritev Corporation's board authorized a $75 million share repurchase program for its Class A common stock, signaling management confidence while potentially supporting stock price and earnings per share.
Feb 23
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Ares Management Llc | 1,863,105 | $80M | — | Dec 2025 |
| 2 | H&f Corporate Investors Viii, Ltd. | 3,887,858 | $64M | — | Mar 2026 |
| 3 | Beach Point Capital Management Lp | 795,346 | $13M | Added | Mar 2026 |
| 4 | Morgan Stanley | 210,734 | $9M | Added | Dec 2025 |
| 5 | Cpv Partners, Llc | 495,258 | $8M | — | Mar 2026 |
| 6 | Vanguard Capital Management Llc | 430,068 | $7M | New | Mar 2026 |
| 7 | Prudential Financial Inc | 353,744 | $6M | — | Mar 2026 |
| 8 | Rbf Capital, Llc | 270,628 | $4M | Added | Mar 2026 |
| 9 | Barclays Plc | 241,783 | $4M | Added | Mar 2026 |
| 10 | Nomura Holdings Inc | 126,116 | $2M | Added | Mar 2026 |
| 11 | Bank Of America Corp /de/ | 97,795 | $2M | Added | Mar 2026 |
| 12 | Point72 Asset Management | 89,444 | $1M | Added | Mar 2026 |
| 13 | Citigroup Inc | 32,232 | $1M | Reduced | Dec 2025 |
| 14 | Aperture Investors, Llc | 80,720 | $1M | — | Mar 2026 |
| 15 | Vanguard Portfolio Management Llc | 71,653 | $1M | New | Mar 2026 |
| 16 | Marshall Wace, Llp | 70,969 | $1M | New | Mar 2026 |
| 17 | Northern Trust Corp | 66,238 | $1M | Added | Mar 2026 |
| 18 | Renaissance Technologies Llc | 51,915 | $848K | Reduced | Mar 2026 |
| 19 | Third Point Llc | 44,000 | $719K | Reduced | Mar 2026 |
| 20 | Aqr Capital Management Llc | 34,890 | $570K | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$483.5M
Enterprise Value
$5.06B
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.03x
P/B
—
P/S
0.49x
P/FCF
-39.38x
EV/EBITDA
9.79x
Shares Out
16.4M
Financials (TTM)
Revenue
$978.8M
Net Income
-$286.5M
EBITDA
$517.5M
Free Cash Flow
-$12.3M
Op Cash Flow
$117.3M
EPS Basic
$-17.30
EPS Diluted
$-17.33
EPS Forward
$-15.20
Gross Margin
61.1%
Op Margin
4.3%
Net Margin
-29.3%
Balance Sheet
Total Assets
$4.89B
Total Liab.
$5.06B
Total Equity
-$167.2M
Cash
$16.8M
LT Debt
$4.60B
Book Value/Sh
$-10.17
Debt/Equity
-26.64x
Current Ratio
0.86
Quick Ratio
0.86
Returns & Growth
ROE
163.5%
ROA
-5.8%
ROIC
0.7%
Rev Growth YoY
+3.7%
EPS Growth YoY
+83.0%
Price Returns
2W
+7.0%
1M
+3.2%
3M
+86.5%
6M
-53.5%
12M
-34.7%
Technicals
52W High
$72.58
52W Low
$13.47
50d MA
$24.16
200d MA
$35.48
RSI (14)
62.50
ATR (14)
$2.66
Beta
0.54
Avg Volume
190K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$32.00
High
$38.00
Low
$28.00
Median
$30.00
Data updated apr 25, 2026 3:40am
· Source: financialmodelingprep.com